Dietary supplements that make claims to “treat disease” suddenly become classified as drugs.


The FDA has issued a regulation entitled Certain Types of Statements for Dietary Supplements, which describes the types of claims that can and can not be made for dietary supplements. This regulation attempts to separate prohibited, “disease claims” (those which claim that the product will diagnose, mitigate, treat, cure, or prevent disease) from permissible “structure-function” claims.
To summarize relevant parts of this long and complication regulation:
• “disease” “refers to damage to an organ part, structure, or system of the body such that it does not function preoperly (e.g., cardiovascular disease), or a state of health leading to such dysfunctioning;”
• Disease claims can be not only express (e.g., made as statements or claims on the label), but also implied by the name of a product (for example, “herbal Prozac” and “antiobiotic”).
Further, in determining whether an express or implied disease claim has been made, the FDA will look at whether statement claims that the product:

(1) Has an effect on a specific disease or class of diseases; (2) has an effect, using scientific or lay terminology, on one or more signs or symptoms that are recognizable to health care professionals or consumers as being characteristic of a specific disease or of a number of different specific diseases; (3) has an effect on a consequence of a natural state that presents a characteristic set of signs or symptoms recognizable to health care professionals or consumers as constituting an abnormality of the body; (4) has an effect on disease through one or more of the following factors: (a) The name of the product; (b) a statement about the formulation of the product, including a claim that the product contains an ingredient that has been regulated by FDA as a drug and is well known to consumers for its use in preventing or treating a disease; (c) citation of a publication or reference, if the citation refers to a disease use; (d) use of the term “disease” or “diseased;” or (e) use of pictures, vignettes, symbols, or other means; (5) belongs to a class of products that is intended to diagnose, mitigate, treat, cure, or prevent a disease; (6) is a substitute for a product that is a therapy for a disease; (7) augments a particular therapy or drug action; (8) has a role in the body’s response to a disease or to a vector of disease; (9) treats, prevents, or mitigates adverse events associated with a therapy for a disease and manifested by a characteristic set of signs or symptoms; or (10) otherwise suggests an effect on a disease or diseases.

Our law office represents companies who need legal assistance with their dietary supplement or cosmetic labels and labeling. We also handle medical device and other FDA issues. The regulatory distinctions are sometimes very subtle and one has to know where to look for answers.
Michael H. Cohen is a California lawyer, New York attorney, Massachusetts lawyer, and Washington, D.C. lawyer and providing business legal advice to entrepreneurs, and health care law advice to businesses and clinicians in the wellness industry. He represents individual entrepreneurs whose businesses are taking off vertically. He also advises medical spas and integrative medicine clinics, physicians, chiropractors, naturopathic physicians, massage therapists, energy healers, nutritionists and herbalists and others, as well as companies with new technologies including quantum, resonance, and other bio-energy devices. He is also known as a spiritual lawyer, because of his interest in numerous alternative medicine modalities, and in advising entrepreneurs and businesses with legal advice that is grounded yet intuitive. Read the Entrepreneur’s Legal Toolkit for legal issues affecting small, medium, and emerging businesses. To speak with a lawyer about health care law issues pertaining to complementary and alternative medicine, or to consult a business lawyer about legal issues for entrepreneurs and new enterprises that are organizing or seeking investors, contact the Law Offices of Michael H. Cohen today.